Table 1—

Patient characteristics

Number of patients22
Age (years)63.7 ± 1.8 (41–76)*
Sex13 males, 9 females
BMI (kg/m2)32.8 ± 1.4
Type of diabetes2 type 1, 20 type 2
Duration of diabetes (years)9.1 ± 1.5
Duration of neuropathy (years)3.0 ± 0.5
Duration of neuropathic pain (years)2.5 ± 0.4
Treatment order10 ISDN, 12 placebo
HbA1c (%)
 At study entry7.8 ± 0.3
 At study completion8.1 ± 0.4
  • *

    * Data are n or means ± SE. Age range;

  • HbA1c reference range 4.9–6.3%.